4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0001209191-15-054839
CIK 0001114220operating
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 8:01 PM ET
Size
7.1 KB
Accession
0001209191-15-054839
Insider Transaction Report
Form 4
Regan Daniel Paul
Director
Transactions
- Award
Common Stock
2015-06-17+10,000→ 30,000 total - Award
Stock Option (right to buy)
2015-06-17+30,000→ 30,000 totalExercise: $9.95From: 2016-06-17Exp: 2025-06-17→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 17, 2016, June 17, 2017 and June 17, 2018.
- [F2]Includes 26,666 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 17, 2016, June 17, 2017 and June 17, 2018.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 8:01 PM ET
- Size
- 7.1 KB